A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detaylı Bibliyografya
Yazar:	Islam, Saidul
Diğer Yazarlar:	Sharmin, Shahana
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2022
Konular:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Online Erişim:	http://hdl.handle.net/10361/17308

Benzer Materyaller

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Yazar:: Karim, Azrin
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Yazar:: Meem, Manila
Baskı/Yayın Bilgisi: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Yazar:: Alam, Tahera
Baskı/Yayın Bilgisi: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
Yazar:: Ahmed, Nafisa
Baskı/Yayın Bilgisi: (2023)

Immunotherapy in the Management of Lung Cancer
Yazar:: Tasnim, Humayra
Baskı/Yayın Bilgisi: (2022)

A review on triple-negative breast cancer and its potential treatment
Yazar:: Niasa, Jannatul Ferdous
Baskı/Yayın Bilgisi: (2023)

Stem cells as therapeutic carrier in cancer treatment
Yazar:: Anika, Mysha Yeasmin
Baskı/Yayın Bilgisi: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Yazar:: Hasan, Amit
Baskı/Yayın Bilgisi: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Yazar:: Chakraborty, Anuradha
Baskı/Yayın Bilgisi: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Yazar:: Khan, Muidul Hasan
Baskı/Yayın Bilgisi: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
Yazar:: Roy, Hredita
Baskı/Yayın Bilgisi: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
Yazar:: Emon, Kamrul Hasan
Baskı/Yayın Bilgisi: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Yazar:: Mirza, Maisa Tasnim
Baskı/Yayın Bilgisi: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
Yazar:: Khan, Rezia Nowrin
Baskı/Yayın Bilgisi: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
Yazar:: Nuha, Nabiha Tahsin
Baskı/Yayın Bilgisi: (2024)

Role of statins as antagonists of SPARC in gastric cancer
Yazar:: Shahmat, Rad
Baskı/Yayın Bilgisi: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Yazar:: Sorno, Rubina Haque
Baskı/Yayın Bilgisi: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Yazar:: Ratu, Tabassum
Baskı/Yayın Bilgisi: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
Yazar:: Choki, Kinley
Baskı/Yayın Bilgisi: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

A comprehensive review on drug repurposing in cancer treatment
Yazar:: Sarkar, Onusree
Baskı/Yayın Bilgisi: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
Yazar:: Mahaleka, Aarshi
Baskı/Yayın Bilgisi: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Yazar:: Shaikat, Mahdi Mubin
Baskı/Yayın Bilgisi: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
Yazar:: Hasan, Sakib
Baskı/Yayın Bilgisi: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Yazar:: Nawar, Anika
Baskı/Yayın Bilgisi: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
Yazar:: Deeba, Maliha Tasnim
Baskı/Yayın Bilgisi: (2018)

Targeting BRAFV600E in the treatment of CRC
Yazar:: Roja, Mashwiyat Samrin
Baskı/Yayın Bilgisi: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Yazar:: Rahman, Sanjida
Baskı/Yayın Bilgisi: (2024)

Biosimilar in lymphoma treatment
Yazar:: Tanisha, Mehrin Haque
Baskı/Yayın Bilgisi: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Yazar:: Khondokar, Faiza
Baskı/Yayın Bilgisi: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Yazar:: Islam, Nahidul
Baskı/Yayın Bilgisi: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
Yazar:: Beruni, Sajid Mahmud Al
Baskı/Yayın Bilgisi: (2022)

Oncogenes: new targets in cancer treatment
Yazar:: Chowdhury, Waseka Shams
Baskı/Yayın Bilgisi: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
Yazar:: Muntaha, Habibatul
Baskı/Yayın Bilgisi: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Yazar:: Haque, Mushfiqul
Baskı/Yayın Bilgisi: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Karim, Samia Binte
Baskı/Yayın Bilgisi: (2024)